Jun 10, 2020 / 01:40PM GMT
Graig Suvannavejh - Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst
Okay. Good morning, everyone. Welcome to the 9:40 session of the Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I cover European and U.S. biopharma for the firm.
I've got the great pleasure of hosting Autolus this morning. And with us from the company are Christian Itin, Chairman and CEO of the company; as well as Andrew Oakley, who's the Chief Financial Officer of the company. So with that, thank you both for joining us.
Questions and Answers:
Graig Suvannavejh - Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research AnalystPerhaps what I'll do is I'll just start from a very high level, and I'll start with you, Christian. CEO of the company, and you've been with the company from relatively early days. But if you could tell us kind of where the company is today relative to kind of the original vision of the company, and how do you feel you're executing on